Doliver Advisors LP decreased its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 4.1% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 7,866 shares of the company’s stock after selling 333 shares during the quarter. Doliver Advisors LP’s holdings in Procter & Gamble were worth $1,319,000 as of its most recent SEC filing.
Several other institutional investors have also recently made changes to their positions in PG. Concurrent Investment Advisors LLC increased its holdings in shares of Procter & Gamble by 4.5% in the 3rd quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock valued at $16,300,000 after acquiring an additional 4,035 shares during the period. Copley Financial Group Inc. bought a new stake in Procter & Gamble during the third quarter valued at about $668,000. Synovus Financial Corp grew its stake in Procter & Gamble by 3.4% in the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after purchasing an additional 6,077 shares during the last quarter. Radnor Capital Management LLC bought a new position in Procter & Gamble in the third quarter worth about $5,705,000. Finally, Welch Group LLC lifted its position in shares of Procter & Gamble by 0.9% during the third quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after buying an additional 2,990 shares during the last quarter. Hedge funds and other institutional investors own 65.77% of the company’s stock.
Insider Transactions at Procter & Gamble
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total transaction of $338,640.00. Following the completion of the transaction, the chief executive officer now owns 13,783 shares of the company’s stock, valued at $2,343,110. This represents a 12.63 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total value of $2,163,072.00. Following the completion of the sale, the insider now directly owns 11,566 shares in the company, valued at $1,954,538.34. This represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,439 shares of company stock valued at $13,317,460 in the last three months. 0.18% of the stock is currently owned by company insiders.
Procter & Gamble Stock Performance
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The business had revenue of $21.74 billion for the quarter, compared to analyst estimates of $21.99 billion. During the same period in the prior year, the company posted $1.83 EPS. The company’s revenue for the quarter was down .6% on a year-over-year basis. As a group, research analysts anticipate that The Procter & Gamble Company will post 6.94 EPS for the current year.
Procter & Gamble Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were given a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.50%. The ex-dividend date was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.31%.
Analyst Ratings Changes
Several research analysts recently commented on the stock. JPMorgan Chase & Co. boosted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research note on Thursday, September 19th. Barclays downgraded Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research report on Monday, September 30th. Wells Fargo & Company boosted their target price on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research note on Friday, November 22nd. Hsbc Global Res upgraded Procter & Gamble to a “strong-buy” rating in a research note on Friday, October 4th. Finally, Royal Bank of Canada restated a “sector perform” rating and set a $164.00 price target on shares of Procter & Gamble in a research note on Monday, October 21st. Eight equities research analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and a consensus price target of $180.45.
Check Out Our Latest Analysis on PG
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What Are Dividend Contenders? Investing in Dividend Contenders
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- Dividend Capture Strategy: What You Need to Know
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Buy P&G Now, Before It Sets A New All-Time High
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.